First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM
YolTech Therapeutics today announced that the first patient has been dosed with YOLT-201, the company's first in vivo genome editing candidate being...
YolTech Therapeutics today announced that the first patient has been dosed with YOLT-201, the company's first in vivo genome editing candidate being...
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company today announced that its Investigational New Drug Application...
LANGaware, an innovative digital assessment tool, is excited to announce its transformative collaboration with BThere Healthcare, a pioneering healthcare provider...
Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, has entered into a collaboration with Rutgers Cancer Institute of New Jersey to use Haystack...
Mission Therapeutics ("Mission" or the "Company"), a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, today announces that the US Food...
Alkermes plc (Nasdaq: ALKS) today announced that it has entered into a definitive agreement to sell its development and manufacturing facility in...
Venus Remedies Limited, a leading fixed-dosage injectable manufacturer, has reached a significant milestone with a marketing authorisation from Azerbaijan for...
In a groundbreaking survey conducted by the Indian Medical Academy for Preventive Health (IMAPH), prominent doctors in India underwent scrutiny...
Sterling Accuris Diagnostics, a leading chain of NABL-accredited pathology laboratories has announced theacquisition of Ahmedabad based Vaibhav Analytical Services, a...
In a significant recognition of excellence in the field of food safety, Dr. Umesh Kamble, the visionary leader at F2F...